SBMFF:OTCMKTS
Sino Biopharmaceutical Ltd
0,76 US$
0,00%
(0,00) 1K
15-apr, 11:31:08 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoSBMFF tikeri uchun statistika yaratilmoqda...
Bozor kapitali
101,60 mlrd
Oʻrtacha hajm
171,00
Hajmi
0,00
52 haftalik eng yuqori
1,24 US$
52 haftalik eng past
0,49 US$
Beta
0,70
Muomaladagi aksiyalar
18,75 mlrd
Xodimlar soni
21 ming
Yangiliklar
Internetdagi manbalardan
Investing.com
·
3 daqiqa oldin
BTIG: S&P 500 Tech posts largest monthly gain since 2002, up 17% in April
Kiplinger
·
8 daqiqa oldin
What the Nasdaq's New 'Fast Entry' Rule Means for Investors
Simply Wall Street
·
12 daqiqa oldin
Earnings Beat: Rush Enterprises, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Yahoo! Finance Canada
·
28 daqiqa oldin
Esperion to be Acquired by ARCHIMED
Profil
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Sino Biopharmaceutical Ltd haqida
AI kontentda xatolar boʻlishi mumkin. Batafsil